BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Scope & Guideline

Championing impactful research in endocrinology and metabolism.

Introduction

Immerse yourself in the scholarly insights of BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1521-690x
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1999 to 2024
AbbreviationBEST PRACT RES CL EN / Best Pract. Res. Clin. Endoc. Metab.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM focuses on the latest advancements in clinical endocrinology and metabolism, providing a platform for high-quality research and comprehensive reviews in the field.
  1. Clinical Endocrinology:
    The journal emphasizes clinical practice in endocrinology, including the diagnosis and management of endocrine disorders such as acromegaly, growth hormone deficiency, and various thyroid conditions.
  2. Hormonal Treatments and Therapies:
    Research on hormonal treatments, particularly in special populations such as transgender individuals and menopausal women, is a core focus, addressing both therapeutic efficacy and safety.
  3. Metabolic Disorders:
    The journal covers metabolic disorders linked to endocrine dysfunction, including obesity, diabetes, and cardiovascular health, with a focus on their pathophysiology and treatment options.
  4. Emerging Therapies and Innovations:
    It includes studies on novel therapeutic approaches and technologies in endocrinology, highlighting advancements in drug development and treatment methodologies.
  5. Gender and Sexual Health in Endocrinology:
    A unique contribution of the journal is its focus on gender-specific health issues, including the endocrinological implications of gender-affirming treatments and menopause management.
The journal has seen a rise in specific themes that reflect current trends and emerging areas of interest within clinical endocrinology and metabolism.
  1. Transgender Health and Endocrinology:
    Recent publications focus heavily on transgender health, including hormone treatments and their implications, reflecting a growing recognition of the need for tailored medical approaches in this population.
  2. Menopause and Women's Health:
    Research on menopause management, including hormonal and non-hormonal therapies, has gained traction, highlighting the increasing importance of women's health issues in endocrinology.
  3. Acromegaly Treatment Advances:
    There is a clear trend towards exploring new treatment modalities for acromegaly, including innovative drugs and surgical techniques, indicating a commitment to improving patient outcomes.
  4. Impact of COVID-19 on Endocrine Disorders:
    The COVID-19 pandemic has spurred a significant increase in research related to its effects on endocrine health, particularly concerning metabolic syndrome and diabetes, showcasing the intersection of infectious diseases and endocrinology.
  5. Personalized and Precision Medicine in Endocrinology:
    Emerging themes highlight the shift towards personalized treatment strategies in endocrinology, including genetic testing and tailored therapies for various endocrine conditions.

Declining or Waning

In recent years, certain themes within the journal have shown a decline in frequency and prominence, reflecting shifts in research interest and clinical focus.
  1. General Endocrine Disruption Studies:
    There has been a noticeable decrease in publications addressing general studies on endocrine-disrupting chemicals, suggesting a shift towards more specific endocrine disorders and their direct clinical implications.
  2. Historical Perspectives on Endocrine Disorders:
    Papers focusing on historical or retrospective analyses of endocrine disorders have become less common, indicating a move towards contemporary research and future-oriented studies.
  3. Basic Science of Endocrinology:
    The journal appears to be moving away from basic scientific studies in endocrinology, favoring clinical applications and translational research that directly impacts patient care.

Similar Journals

ENDOCRINE RESEARCH

Connecting researchers to the pulse of endocrine science.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Exploring Breakthroughs in Endocrinology and Metabolism
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pioneering Research in Hormones and Metabolism
Publisher: OXFORD UNIV PRESSISSN: 0804-4643Frequency: 12 issues/year

EUROPEAN JOURNAL OF ENDOCRINOLOGY, published by Oxford University Press, stands as a premier international platform dedicated to advancing research in the burgeoning field of endocrinology, diabetes, and metabolism. Since its inception in 1994, this esteemed journal has gained recognition for its rigorous peer-reviewed articles and innovative studies, evidenced by its impressive Q1 rankings across multiple categories, including Endocrinology and Medicine. With a focus on disseminating critical findings and fostering interdisciplinary collaboration, the journal ranks 33rd out of 244 in Endocrinology, Diabetes, and Metabolism, and 20th out of 128 in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics, positioning it in the top percentiles for researchers worldwide. Although it does not offer open access, the journal remains a vital resource for academics and practitioners alike who seek to stay at the forefront of endocrine research. The EUROPEAN JOURNAL OF ENDOCRINOLOGY continues to push the boundaries of knowledge, driving forward the understanding of complex hormonal functions and their clinical implications.

Frontiers in Endocrinology

Innovating Understanding in Metabolic Disorders
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elevating Clinical Standards Through Rigorous Research
Publisher: ENDOCRINE SOCISSN: 0021-972XFrequency: 12 issues/year

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

Hormone Molecular Biology and Clinical Investigation

Connecting Molecular Insights with Clinical Applications
Publisher: WALTER DE GRUYTER GMBHISSN: 1868-1883Frequency: 12 issues/year

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Endocrinology Diabetes and Metabolism Case Reports

Advancing Knowledge in Endocrinology and Metabolism
Publisher: BIOSCIENTIFICA LTDISSN: Frequency: 1 issue/year

Endocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.

Hormones-International Journal of Endocrinology and Metabolism

Exploring the Nexus of Endocrinology and Metabolism
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

Cardiovascular Endocrinology & Metabolism

Unlocking the Connections Between Heart and Hormonal Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

HORMONE AND METABOLIC RESEARCH

Driving Innovation in Endocrine and Metabolic Studies
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.